Evolent Health
131 hedge funds and large institutions have $921M invested in Evolent Health in 2017 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 17 closing their positions.
Holders
131
Holders Change
+13
Holders Change %
+11.02%
% of All Funds
3.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
36
Increased
49
Reduced
30
Closed
17
Calls
$5.98M
Puts
$1.3M
Net Calls
+$4.68M
Net Calls Change
+$2.88M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$113M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$101M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$50.5M |
| 4 |
PA
4
Perceptive Advisors
New York
|
$32.2M |
| 5 |
5
Millennium Management
New York
|
$31.2M |
